Zobrazeno 1 - 10
of 298
pro vyhledávání: '"Cheng-Hwai, Tzeng"'
Autor:
Muh-Hwa Yang, Jung-Yie Kao, Kou-Juey Wu, Cheng-Hwai Tzeng, Cheng-Chi Chang, Tung-Lung Tsai, Shyue-Yih Chang, Shyh-Kuan Tai, Chi-Hung Huang, Hsin-Yi Lan, Dennis Shin-Shian Hsu
Supplementary Figures S1-S8 and Supplementary Tables S1-S8.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8f70d297e1f04d457b686acd547a6ee
https://doi.org/10.1158/1078-0432.22440847
https://doi.org/10.1158/1078-0432.22440847
Autor:
Muh-Hwa Yang, Jung-Yie Kao, Kou-Juey Wu, Cheng-Hwai Tzeng, Cheng-Chi Chang, Tung-Lung Tsai, Shyue-Yih Chang, Shyh-Kuan Tai, Chi-Hung Huang, Hsin-Yi Lan, Dennis Shin-Shian Hsu
Purpose: We investigated the mechanism and clinical significance of the epithelial-mesenchymal transition (EMT)-induced chemoresistance in head and neck squamous cell carcinoma (HNSCC).Experimental Design: The correlation between the expression of di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ac313d1b877ad1db6cbd392d2a1c647
https://doi.org/10.1158/1078-0432.c.6518110
https://doi.org/10.1158/1078-0432.c.6518110
Autor:
Muh-Hwa Yang, Cheng-Hwai Tzeng, Cheng-Chi Chang, Yann-Jang Chen, Ya-Wei Chen, Dennis Shin-Shian Hsu, Shyh-Kuan Tai, Ting-Yun Liu, Neng-Kai Yang, Chun-Hung Chou
PDF file - 95KB, Sequence of the oligonucleotides for shRNA construct-making, reverse transcription, real-time PCR, and ChIP assay (S1); List of proteins tested by antibodies and characteristics of the corresponding antibodies (S2); Expression profil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f1f1bf55e54815fbd9aa9fd0084b211
https://doi.org/10.1158/0008-5472.22400259.v1
https://doi.org/10.1158/0008-5472.22400259.v1
Autor:
Muh-Hwa Yang, Cheng-Hwai Tzeng, Cheng-Chi Chang, Yann-Jang Chen, Ya-Wei Chen, Dennis Shin-Shian Hsu, Shyh-Kuan Tai, Ting-Yun Liu, Neng-Kai Yang, Chun-Hung Chou
Chromosomal instability (CIN) is widely considered a hallmark of cancer, but its precise roles in cancer stem cells (CSC) and malignant progression remain uncertain. BMI1 is a member of the Polycomb group of chromatin-modifier proteins that is essent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29288c1e56df8dbb28875b00ab0e9f02
https://doi.org/10.1158/0008-5472.c.6505539
https://doi.org/10.1158/0008-5472.c.6505539
Autor:
Muh-Hwa Yang, Cheng-Hwai Tzeng, Cheng-Chi Chang, Yann-Jang Chen, Ya-Wei Chen, Dennis Shin-Shian Hsu, Shyh-Kuan Tai, Ting-Yun Liu, Neng-Kai Yang, Chun-Hung Chou
PDF file -810KB, Twist1 upregulates Bmi1 and aurora kinase A expression, and co-amplification of BMI1 and AURKA in CD44+ HNSCC cells (S1); Akt pathway and let-7i repression are two independent mechanisms induced by Bmi1 to regulate aurora kinase A ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83798980026571559d6cb2848161b4aa
https://doi.org/10.1158/0008-5472.22400268.v1
https://doi.org/10.1158/0008-5472.22400268.v1
Autor:
Muh-Hwa Yang, Cheng-Hwai Tzeng, Cheng-Chi Chang, Yann-Jang Chen, Ya-Wei Chen, Dennis Shin-Shian Hsu, Shyh-Kuan Tai, Ting-Yun Liu, Neng-Kai Yang, Chun-Hung Chou
PDF file - 104KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac23cdec99584e04d827a05d950375f
https://doi.org/10.1158/0008-5472.22400271
https://doi.org/10.1158/0008-5472.22400271
Autor:
Sheng-Hsuan Chien, Yao-Chung Liu, Ying-Chung Hong, Ching-Fen Yang, Chun-Yu Liu, Tzeon-Jye Chiou, Cheng-Hwai Tzeng, Jin-Hwang Liu, Jyh-Pyng Gau
Publikováno v:
Journal of Cancer Research and Practice, Vol 3, Iss 2, Pp 45-48 (2016)
Systemic mastocytosis is a rare disease and characterized by excessive mast cell accumulation in one or multiple organs. One subtype of systemic mastocytosis is systemic mastocytosis-associated clonal hematological non-mast cell lineage disease (SM-A
Externí odkaz:
https://doaj.org/article/cca2a695a27844efa0fb860748ddeda9
Publikováno v:
Journal of Cancer Research and Practice, Vol 2, Iss 1, Pp 42-48 (2015)
Lung cancer is the leading cause of death from cancer worldwide. Almost 60% of patients with non-small cell lung cancer present with metastasis at the time of diagnosis. Without treatment, the median survival for patients with metastatic non-small ce
Externí odkaz:
https://doaj.org/article/95492c257e2e40d7ab0b0cc4a56acdc2
Autor:
Po-Shen Ko, Yao-Chung Liu, Chiu-Mei Yeh, Jyh-Pyng Gau, Yuan-Bin Yu, Liang-Tsai Hsiao, Cheng-Hwai Tzeng, Po-Min Chen, Tzeon-Jye Chiou, Chia-Jen Liu, Jin-Hwang Liu
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0172029 (2017)
We reviewed 97 consecutive cases of myeloid neoplasm with erythroid predominance (MN-EP) between 2000 and 2015. Following 2016 WHO classification, MN-EP patients were classified into four groups. Eight pure erythroid leukemia (PEL) (including t-MN an
Externí odkaz:
https://doaj.org/article/18ec65ca068043a29f904c4cdbc082f7
Publikováno v:
Journal of Cancer Research and Practice, Vol 1, Iss 1, Pp 46-49 (2014)
Ifosfamide is an alkylating antineoplastic prodrug used to treat many solid tumors. The metabolism of ifosfamide is via CYP450 3A4 and 2B6 and produces active ifosfamide mustard, the toxic metabolite acrolein and chloroacetaldehyde (CAA). Additionall
Externí odkaz:
https://doaj.org/article/d9407c7c1e904efc9b9798db097cc926